Clinicopathological Conference, Powasan Virus Encephalitis
NEJM 393:176-184, Case 19-2025, 2025
Natalizumab Plus Interferon Beta -1a for Relapsing Multiple Sclerosis
NEJM 354:911-923,965, Rudick,R.A.,et al, 2006
A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
NEJM 354:899-910,965, Polman,C.H.,et al, 2006
Cognitive Assessment of Human Immunodeficiency Virus-Exposed Children
Am J Dis Child 146:1479-1483, Levenson,R.L.,et al, 1992
Acquired Immunodeficiency Syndrome, CSF Before & During Long-Term Oral Zidovudine Therapy
Arch Neurol 48:695-699, Tartaglione,T.A.,et al, 1991